Efficacy and Safety of Ipragliflozin (IPRA) in Japanese Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by Body Mass Index (BMI)

被引：0
作者：
Kashiwagi, Atsunori
Yoshida, Satoshi
Nakamura, Ichiro
Kazuta, Kenichi
Ueyama, Eiji
Takahashi, Hideyuki
Satomi, Hayato
Kosakai, Yoshinori
Kawamuki, Kousei
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1197-P
引用
收藏
页码：A309 / A309
页数：1
相关论文
共 50 条
[21]   Efficacy and Safety of Ipragliflozin in Japanese Type 2 Diabetic Patients [J].
Takihata, Masahiro ;
Terauchi, Yasuo .
DIABETES, 2015, 64 :A311-A311
[22]   Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM) [J].
Weinzimer, SA ;
McKnight, WJ ;
Murphy, K ;
Jawad, AF ;
Celona-Jacobs, N ;
Haque, A ;
Katz, LEL .
DIABETES, 2001, 50 :A68-A68
[23]   Microvascular complications in type 2 diabetes mellitus (T2DM). [J].
Cheung, AT ;
Ramanujam, S ;
Duong, PL ;
Schauer, D ;
Chan, LS ;
Dwyre, DM ;
Larkin, EC .
FASEB JOURNAL, 2002, 16 (04) :A208-A208
[24]   Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM) [J].
Luo, Jian-Quan ;
Shu, Yan ;
Zhang, Wei .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[25]   Vascular responsiveness in type 2 diabetes mellitus (T2DM) [J].
Blum, A. ;
Socea, D. ;
Sirchan, R. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) :791-796
[26]   The platelets characteristics in type 2 diabetes mellitus (T2DM) [J].
Buryachkovskaya, L. ;
Uchitel, I. A. ;
Sumarokov, A. B. ;
Docenko, U., V .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 :931-931
[27]   Efficacy and Safety of Canagliflozin (CANA) Monotherapy in Subjects With Type 2 Diabetes Mellitus (T2DM) Over 52 Weeks [J].
Stenloef, Kaj ;
Cefalu, William T. ;
Kim, Kyoung-Ah ;
Jodar, Esteban ;
Alba, Maria ;
Edwards, Robert ;
Tong, Cindy ;
Canovatchel, William ;
Meininger, Gary .
DIABETES, 2013, 62 :A303-A303
[28]   TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) WITH SITAGLIPTIN-EFFICACY AND SAFETY IN A REAL-LIFE SETTING [J].
Kusterer, K. ;
Ruessmann, H. J. ;
Hens, C. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 :52-52
[29]   Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk [J].
Sonesson, C. ;
Frederich, R. ;
Johansson, P. A. ;
Gause-Nilsson, I. ;
Langkilde, A. M. ;
List, J. F. .
EUROPEAN HEART JOURNAL, 2014, 35 :1072-1072
[30]   Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM) [J].
Ford, Daniel M. ;
Baz-Hecht, Merav ;
Said, Nabil A. ;
Tao, Ben ;
Truitt, Kenneth E. ;
Chou, Hubert S. .
DIABETES, 2013, 62 :A273-A273
12345